Astera Labs, Inc. (ALAB)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
---|---|---|---|---|
Revenue | 191,925 | 159,442 | 113,086 | 76,850 |
Cost of revenue | 46,362 | 40,031 | 25,209 | 16,996 |
Gross profit | 145,563 | 119,411 | 87,877 | 59,854 |
Sales and marketing | 18,609 | 21,702 | 23,248 | 22,076 |
Research and development | 66,724 | 64,554 | 50,659 | 40,089 |
General and administrative | 20,456 | 21,870 | 22,866 | 22,036 |
Total operating expenses | 105,789 | 108,126 | 96,773 | 84,201 |
Operating income (loss) | 39,774 | 11,285 | -8,896 | -24,347 |
Interest income | 10,885 | 10,432 | 10,912 | 10,264 |
Income (loss) before income taxes | 50,659 | 21,717 | 2,016 | -14,083 |
Income tax (benefit) provision | -560 | -10,102 | 9,609 | -6,537 |
Net income (loss) | 51,219 | 31,819 | -7,593 | -7,546 |
Unrealized gain (loss) on marketable securities, net of taxes | 846 | 1,602 | 4,782 | -293 |
Total other comprehensive gain (loss) | 846 | 1,602 | 4,782 | -293 |
Total comprehensive income (loss) | 52,065 | 33,421 | -2,811 | -7,839 |
Basic (in dollars per share) | 0.31 | 0.19 | -0.05 | -0.05 |
Basic (in shares) | 165,428,000 | 163,194,000 | 156,831,000 | 155,199,000 |
Diluted (in dollars per share) | 0.29 | 0.18 | -0.05 | -0.05 |
Diluted (in shares) | 178,100,000 | 178,116,000 | 156,831,000 | 155,199,000 |